As of May 3, 2024, the Insulet stock's PE ratio is 58.93. This takes into account the latest EPS of $2.96 and stock price of $174.43. The PE ratio marks a decrease of 99% from its last 4 quarters average of 8095.6.
The PE ratio of Insulet has averaged 2659.65 over the last six years. The current P/E ratio of 58.93 is 98% lower than the historical average. Looking back at the last six years, PODD's PE ratio peaked in the Mar 2023 quarter at 31,896, when the price was $318.96 and the EPS was $0.01. The lowest point was in the Dec 2023 quarter, when it reached 73.3 with a price of $216.98 and an EPS of $2.96.
Maximum annual increase: 295.16% in 2022
Maximum annual decrease: -98.26% in 2023
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 73.3 | -98.26% |
| 2022 | 4,205.57 | 295.16% |
| 2021 | 1,064.28 | -54.2% |
| 2020 | 2,323.91 | 157.91% |
| 2019 | 901.05 | -31.84% |
| 2018 | 1,322 | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
PODD's current PE ratio is lower than its 3, 5 and 10-year averages.
PODD's PE ratio stands lower than its peer stocks LLY and DXCM, but it is higher than JNJ's and ABT's. Insulet is currently trading at a higher PE ratio (58.93) than its peers average of 36.58.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 9.78 | $359.25B |
| MDT Medtronic plc | 25.93 | $108.47B |
| ABT Abbott Laboratories | 32.79 | $184.23B |
| PODD Insulet Corp | 58.93 | $12.2B |
| DXCM Dexcom Inc | 77.8 | $51.05B |
| LLY ELI LILLY & Co | 107.77 | $698.52B |
| ICUI Icu Medical Inc | N/A | $2.41B |
| DCTH Delcath Systems Inc | N/A | $136.57M |
| TNDM Tandem Diabetes Care Inc | N/A | $2.89B |
PODD stock has a price to earnings ratio of 58.93 as of May 3, 2024.
The average PE ratio for PODD stock over the past 3 years is 4379.27.
The average PE ratio for PODD stock over the past 5 years is 2871.48.
Over the last six years, the quarterly PE ratio reached its highest level at 31,896 in the Mar 2023 quarter.
PODD's price to earnings ratio is currently 98% below its 6-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (May 3, 2024), Insulet's share price is $174.43. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $2.96. Therefore, Insulet's PE ratio for today is 58.93. PE RATIO(58.93) = STOCK PRICE($174.43) / TTM EPS($2.96)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.